Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Convertible Notes Payable Convertible Bond Debt	Warrant Issued For Vessel Consideration	Common Stock	Common Stock Convertible Notes Payable Convertible Bond Debt	Common Stock Warrant Issued For Vessel Consideration	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Convertible Notes Payable Convertible Bond Debt	Additional Paid-in Capital Warrant Issued For Vessel Consideration	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income/(Loss)
Beginning balance (in shares) at Dec. 31, 2020					11,661,797
Beginning balance at Dec. 31, 2020	$ 470,418				$ 117			$ 943,572				$ (472,138)		$ (1,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	184,898											184,898
Dividends	(26,255)											(26,255)
Issuance of shares due to vesting of equity awards (in shares)					81,281
Issuance of shares due to vesting of equity awards	0				$ 1			(1)
Issuance of shares upon exercise of stock options (in shares)					50,641
Issuance of shares upon exercise of stock options	56				$ 1			55
Common stock issued upon conversion (in shares)						25	541,898
Common stock issued upon conversion			$ 1	$ 10,680			$ 5			$ 1	$ 10,675
Common stock issued from ATM Offering, net (in shares)					581,385
Common stock issued from ATM Offering, net	27,138				$ 6			27,133
Fees for equity offerings	(233)							(233)
Cash used to settle net share equity awards	(1,937)							(1,937)
Effect of cash flow hedges	3,019													3,019
Stock-based compensation	3,481							3,481
Ending balance (in shares) at Dec. 31, 2021					12,917,027
Ending balance at Dec. 31, 2021	671,266	$ (12,051)			$ 129			982,746	$ (20,726)			(313,495)	$ 8,675	1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	248,009											248,009
Dividends	(106,745)											(106,745)
Issuance of shares due to vesting of equity awards (in shares)					78,598
Issuance of shares due to vesting of equity awards	0				$ 1			(1)
Issuance of shares upon exercise of stock options (in shares)					8,077
Issuance of shares upon exercise of stock options	85							85
Fees for equity offerings	201							201
Cash used to settle net share equity awards	(2,355)							(2,355)
Effect of cash flow hedges	14,663													14,663
Stock-based compensation	$ 6,108							6,108
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06
Ending balance (in shares) at Dec. 31, 2022					13,003,702
Ending balance at Dec. 31, 2022	$ 819,181				$ 130			966,058				(163,556)		16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,728											22,728
Dividends	(15,899)											(15,899)
Issuance of shares due to vesting of equity awards (in shares)					104,090
Issuance of shares due to vesting of equity awards	0				$ 1			(1)
Repurchase of common stock – related party (Note 9) (in shares)					(3,781,561)
Repurchase of common stock – related party (Note 9)	(222,889)				$ (38)			(222,851)
Cash used to settle net share equity awards	(2,297)							(2,297)
Effect of cash flow hedges	(8,098)													(8,098)
Stock-based compensation	7,492							7,492
Ending balance (in shares) at Dec. 31, 2023					9,326,231
Ending balance at Dec. 31, 2023	$ 600,218				$ 93			$ 748,401				$ (156,727)		$ 8,451